Perfluorodecalin and bone regeneration

European Cells and Materials

Volumn 25, Issue , 2012, Pages 22-36

  Tamimi, F ^a   Comeau, P ^a   Le Nihouannen, D ^b   Zhang, Y L ^a   Bassett, D C ^a   Khalili, S ^a   Gbureck, U ^c   Tran, S D ^a   Komarova, S ^a   Barralet, J E ^a  

^a MCGILL UNIVERSITY   (Canada)

^b UNIVERSITÉ DE BORDEAUX   (France)

^c UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Biomaterials; Bone; Bone marrow; Bone regeneration; Perfluorocarbons; Radiopacity

Indexed keywords

BIOCERAMICS; BONE CEMENT; CALCIUM PHOSPHATE; CALCIUM PHOSPHATE DIBASIC; MOLECULAR SCAFFOLD; PERFLUORODECALIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOCOMPATIBILITY; BONE DEFECT; BONE IMPLANT; BONE MARROW CELL; BONE REGENERATION; BONE TRANSPLANTATION; CELL SURVIVAL; CONTROLLED STUDY; DENSITOMETRY; HYDROPHOBICITY; IN VITRO STUDY; IN VIVO STUDY; MALE; MATERIALS TESTING; MECHANICAL STRESS; MORPHOMETRICS; MOUSE; NANOFABRICATION; NONHUMAN; ORTHOPEDIC SURGERY; PHYSICAL CHEMISTRY; RABBIT; TISSUE ENGINEERING; X RAY ANALYSIS;

EID: 84872094613     PISSN: 14732262     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (60)

1. Alkhraisat MH, Moseke C, Blanco L, Barralet JE, Lopez-Carbacos E, Gbureck U (2008) Strontium modified biocements with zero order release kinetics. Biomaterials 29: 4691-4697.
2. Armstrong S, Pereverzev A, Dixon SJ, Sims SM (2009) Activation of P2X7 receptors causes isoformspecific translocation of protein kinase C in osteoclasts. J Cell Sci 122: 136-144.
3. Arnett TR, Gibbons DC, Utting JC, Orriss IR, Hoebertz A, Rosendaal M, Meghji S (2003) Hypoxia is a major stimulator of osteoclast formation and bone resorption. J Cell Physiol 196: 2-8.
4. Aro H, Eerola E, Aho AJ, Niinikoski J (1984) Tissue Oxygen-tesion in externally stabilized tibial fractures in rabbits during normal healing and infection. J Surg Res 37: 202-207.
5. Barralet JE, Grover LM, Gbureck U (2004) Ionic modification of calcium phosphate cement viscosity. Part II: hypodermic injection and strength improvement of brushite cement. Biomaterials 25: 2197-2203.
6. Bohner M, Doebelin N, Baroud G (2006) Theoretical and experimental approach to test the cohesion of calcium phosphate pastes. Eur Cells Mater 12: 26-35.
7. Brown MF, Gratton TP, Stuart JA (2007) Metabolic rate does not scale with body mass in cultured mammalian cells. Am J Physiol Regul Integr Comp Physiol 292: R2115-R2121.
8. Bueno EM, Glowacki J (2009) Cell-free and cell-based approaches for bone regeneration. Nat Rev Rheumatol 5: 685-697.
9. Caplan AI (1991) Mesenchymal stem-cells. J Orthop Res 9: 641-650.
10. Caplan AI, Dennis JE (2006) Mesenchymal stem cells as trophic mediators. J Cell Biochem 98: 1076-1084.
11. Carey LE, Xu HHK, Simon CG,Takagi S, Chow LC (2005) Premixed rapid-setting calcium phosphate composites for bone repair. Biomaterials 26: 5002-5014.
12. Carmichael J, Degraff WG, Gazdar AF, Minna JD, Mitchell JB (1987) Evaluation of a tetrazoliumbased semiautomated colorimetric assay-assessment of chemosensitivity testing. Cancer Res 47: 936-942.
13. Cheema U, Brown RA, Alp B, MacRobert AJ (2008) Spatially defined oxygen gradients and vascular endothelial growth factor expression in an engineered 3D cell model. Cell Mol Life Sci 65: 177-186.
14. Chen F, Liu C, Mao Y (2010) Bismuth-doped injectable calcium phosphate cement with improved radiopacity and potent antimicrobial activity for root canal filling. Acta Biomater 6: 3199-3207.
15. Connolly JF. Injectable bone marrow preparations to stimulate osteogenic repair (1995) Clin Orthop Relat Res 313: 8-18.
16. Gbureck U, Hozel T, Klammert U, Wurzler K, Muller FA, Barralet JE (2007a) Resorbable dicalcium phosphate bone substitutes prepared by 3D powder printing. Adv Funct Mater 17: 3940-3945.
17. Gbureck U, Vorndran E, Müller FA, Barralet JE. Low temperature direct 3D printed bioceramics and biocomposites as drug release matrices (2007b) J Control Release 122:173-80.
18. Goshima J, Goldberg VM, Caplan AI (1991) The osteoenic potential of cultured-expanded rat marrow mesenchymal cells assayed in vivo in calcium-phosphate ceramic blocks. Clin Orthop Relat Res 262: 298-311.
19. Grayson WL, Zhao F, Bunnell B, Ma T (2007) Hypoxia enhances proliferation and tissue formation of human mesenchymal stem cells. Biochem Biophys Res Commun 358: 948-953.
20. Grayson WL, Zhao F, Izadpanah R, Bunnell B, Ma T (2006) Effects of hypoxia on human mesenchymal stem cell expansion and plasticity in 3D constructs. J CellPhysiol 207: 331-339.
21. Grcevic D, Pejda S, Matthews BG, Repic D, Wang L, Li H, Kronenberg MS, Jiang X, Maye P, Adams DJ, Rowe DW, Aguila HL, Kalajzic I (2012) In vivo fate mapping identifies mesenchymal progenitor cells. Stem Cells 30:187-96.
22. Habibovic P, Gbureck U, Doillon CJ, Bassett DC, van Blitterswijk CA, Barralet JE (2008) Osteoconduction and osteoinduction of low-temperature 3D printed bioceramic implants. Biomaterials 29: 944-953.
23. Holzwarth C, Vaegler M, Gieseke F, Pfister SM, Handgretinger R, Kerst G, Mueller I (2010) Low physiologic oxygen tensions reduce proliferation and differentiation of human multipotent mesenchymal stromal cells. BMC Cell Biol 11:11.
24. Huibregtse BA, Johnstone B, Goldberg VM, Caplan AI (2000) Effect of age and sampling site on the chondro-osteogenic potential of rabbit marrow-derived mesenchymal progenitor cells. J Orthop Res. 18:18-24.
25. Jeng MJ, Yang SS, Wolfson MR, Shaffer TH (2003) Perfluorochemical (PFC) combinations for acute lung injury: an in vitro and in vivo study in juvenile rabbits. Pediatr Res. 53(1):81-88.
26. Jewitt N, Anthony P, Lowe KC, de Pomerai DI (1999) Oxygenated perfluorocarbon promotes nematode growth and stress-sensitivity in a two-phase liquid culture system. Enzyme Microb Technol 25: 349-356.
27. Jiang YH, Jahagirdar BN, Reinhardt RL, Schwartz RE, Keene CD, Ortiz-Gonzalez XR, Reyes M, Lenvik T, Lund T, Blackstad M, Du JB, Aldrich S, Lisberg A, Low WC, Largaespada DA, Verfaillie CM (2002) Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418: 41-49.
28. Kivisaari J, Niinikoski J (1975) Tissue oxygen and carbon-dioxide tensions in healing rabbit tibias. Acta Orthop Scand 46: 269-279.
29. Knowles HJ, Athanasou NA (2009) Acute hypoxia and osteoclast activity: a balance between enhanced resorption and increased apoptosis. J Pathol 218: 256-264.
30. Kon E, Muraglia A, Corsi A, Bianco P, Marcacci M, Martin I, Boyde A, Ruspantini I, Chistolini P, Rocca M, Giardino R, Cancedda R, Quarto R (2000) Autologous bone marrow stromal cells loaded onto porous hydroxyapatite ceramic accelerate bone repair in critical-size defects of sheep long bones. J Biomed Mater Res 49: 328-337.
31. Kruyt MC, Delawi D, Habibovic P, Oner FC, van Blitterswijk CA, Dhert WJA (2009) Relevance of bone graft viability in a goat transverse process model. J Orthop Res 27: 1055-1059.
32. Kurdy NMG, Weiss JB, Bate A (1996) Endothelial stimulating angiogenic factor in early fracture healing. Injury 27: 143-145.
33. Lane TA (1995) Perfluorochemical-based artificial oxygen-carrying red-cell substitutes. Transfus Sci 16: 19-31.
34. Lochner K, Fritsche A, Jonitz A, Hansmann D, Mueller P, Mueller-Hilke B, Bader R (2011) The potential role of human osteoblasts for periprosthetic osteolysis following exposure to wear particles. Int J Mol Med; 28:1055-1063.
35. Long DM, Liu M, Alrenga P, Szanto PS (1971) Application of perfluorocarbon compounds as radiopaque agents. Surg Forum 22: 207-209.
36. Long DM, Liu MS, Szanto PS, Arambulo AS, Rosen AL (1975) Perfluorocarbon compounds as X-ray contrast media in the lungs. Bull Soc Int Chir 34: 137-141.
37. Lowe KC (1991) Perfluorochemicals - blood and beyond. Adv Mater 3: 87-93.
38. Ma T, Grayson WL, Froehlich M, Vunjak-Novakovic G (2009) Hypoxia and stem cell-based engineering of mesenchymal tissues. Biotechnol Prog 25: 32-42.
39. Marcacci M, Kon E, Moukhachev V, Lavroukov A, Kutepov S, Quarto R, Mastrogiacomo M, Cancedda R (2007) Stem cells associated with macroporous bioceramics for long bone repair: 6-to 7-year outcome of a pilot clinical study. Tissue Eng 13: 947-955.
40. Mattrey RF, Strich G, Shelton RE, Gosink BB, Leopold GR, Lee T, Forsythe J (1987) Perfluorochemicals as US contrast agents or tumor imaging and hepatosplenographypreliminary clinical results. Radiology 163: 339-343.
41. McFarland E, Koutcher JA, Rosen BR, Teicher B, Brady TJ (1985) In vivo F-19 NMR imaging. J Comput Assist Tomogr 9: 8-15.
42. Meijer GJ, de Bruijn JD, Koole R, van Blitterswijk CA (2008) Cell based bone tissue engineering in jaw defects. Biomaterials 29: 3053-3061.
43. Meirelles LdS, Fontes AM, Covas DT, Caplan AI (2009) Mechanisms involved in the therapeutic properties of mesenchymal stem cells. Cytokine Growth Fact Rev 20: 419-427.
44. Ohgushi H, Goldberg VM, Caplan AI (1989) Heterotopic osteogenesis in porous ceramics induced by marrow-cells. J Orthop Res 7: 568-578.
45. Otto WR (2005) Fluorimetric DNA assay of cell number. Methods Mol Biol 289: 251-262
46. Pilarek M, Szewczyk KW (2008) Effects of perfluorinated oxygen carrier application in yeast, fungi and plant cell suspension cultures. Biochem Eng J 41: 38-42.
47. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284: 143-147.
48. Putyatina TK, Aprosin UD, Afonin NI (1994) The elimination peculiarities of perfluorocarbon emulsions stabilized with egg yolk phospholipid. Artif Cells Blood Substit Immobil Biotechnol 22:1281-1285.
49. Rago R, Mitchen J, Wilding G (1990) DNA fluorometric assay in 96-well tissue-culture plates using Hoechst-33258 after cell-lysis by freezing in distilled water. Anal Biochem 191: 31-34.
50. Riess JG, Krafft MP (1998) Fluorinated materials for in vivo oxygen transport (blood substitutes), diagnosis and drug delivery. Biomaterials 19: 1529-1539.
51. Riess JG, Arlen C, Greiner J, Leblanc M, Manfredi A, Pace S, Varescon C, Zarif L (1988) Design, synthesis and evaluationof fluorocarbons and surfactants for in vivo application new polyhydroxylated surfactants. Biomater Artif Cell Artif Organs 16: 421-430.
52. Roser BJ, Garcia De Castro A, Maki J (1999) Composition anf method for stable injectable liquids. In: US patent 6'190'701, Cambridge Biostability Ltd., UK.
53. Sengupta S, Park S-H, Patel A, Carn J, Lee K, Kaplan DL (2010) Hypoxia and Amino Acid Supplementation Synergistically Promote the Osteogenesis of Human Mesenchymal Stem Cells on Silk Protein Scaffolds. Tissue Eng Part A 16: 3623-3634.
54. Soman N, Banerjee R (2003) Artificial vitreous replacements. Biomed Mater Eng 13: 59-74.
55. Song-Ling L, Maturu KP(1975). Permanent suspension pharmaceutical dosage form. In: US Patent 3'996'355, American Home Prod Corp, USA.
56. Tamimi F, Torres J, Gbureck U, Lopez-Cabarcos E, Bassett DC, Alkhraisat MH, Barralet JE (2009a) Craniofacial vertical bone augmentation: A comparison between 3D printed monolithic monetite blocks and autologous onlay grafts in the rabbit. Biomaterials 30: 6318-6326.
57. Tamimi F, Torres J, Lopez-Cabarcos E, Bassett DC, Habibovic P, Luceron E, Barralet JE (2009b) Minimally invasive maxillofacial vertical bone augmentation using brushite based cements. Biomaterials 30: 208-216.
58. Tan Q, El-Badry AM, Contaldo C, Steiner R, Hillinger S, Welti M, Hilbe M, Spahn DR, Jaussi R, Higuera G, van Blitterswijk CA, Luo Q, Weder W (2009) The effect of perfluorocarbon-based artificial oxygen carriers on tissueengineered trachea. Tissue Eng Part A 15: 2471-2480.
59. Xu HHK, Carey LE, Simon CG Jr, Takagi S, Chow LC (2007) Premixed calcium phosphate cements: Synthesis, physical properties, and cell cytotoxicity. Dent Mater 23: 433-441.
60. Yu T, Ye J, Wang Y (2009) Preparation and characterization of a novel strontium-containing calcium phosphate cement with the two-step hydration process. Acta Biomater 5: 2717-2727.